David E. Geller
Arcturus Therapeutics (United States)(US)
Publications by Year
Research Areas
Cystic Fibrosis Research Advances, Inhalation and Respiratory Drug Delivery, Asthma and respiratory diseases, Neonatal Respiratory Health Research, Pneumonia and Respiratory Infections
Most-Cited Works
- → Ivacaftor in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation(2012)329 cited
- → Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial(2010)312 cited
- → Development of an Inhaled Dry-Powder Formulation of Tobramycin Using PulmoSphere™ Technology(2011)303 cited
- → Pharmacokinetics and Bioavailability of Aerosolized Tobramycin in Cystic Fibrosis(2002)302 cited
- → Pulmonary exacerbations in cystic fibrosis(2004)249 cited
- → Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis(1999)200 cited
- → Novel tobramycin inhalation powder in cystic fibrosis subjects: Pharmacokinetics and safety(2007)